AH
CALA

Andreas Halvorsen’s Calithera Biosciences, Inc CALA Stock Holding History

Andreas Halvorsen’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-82,184
Closed -$13.7M – 78
2017
Q4 		$13.7M Sell
82,184
-49,043
-37% -$12.6M 0.08% 56
2017
Q3 		$41.3M Buy
131,227
+10,211
+8% +$3.22M 0.27% 50
2017
Q2 		$35.9M Buy
121,016
+5,735
+5% +$1.53M 0.24% 49
2017
Q1 		$26.6M Buy
+115,281
New +$19.9M 0.12% 60

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Andreas Halvorsen's CALA Position: Q1 2018 in Review

Andreas Halvorsen sold out of Calithera Biosciences, Inc (CALA) in Q1 2018, closing a stake of 82,184 shares — an estimated $13.7M sold.

Andreas Halvorsen first reported a position in CALA in Q1 2017 and held it in 4 quarters. The position peaked at $41.3M in Q3 2017. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2018.

  • Andreas Halvorsen reported no remaining Calithera Biosciences, Inc position as of Q1 2018 after selling out during the quarter.
  • Andreas Halvorsen sold 82,184 Calithera Biosciences, Inc shares in Q1 2018, an estimated $13.7M.
  • Andreas Halvorsen first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 4 quarters.
  • Andreas Halvorsen's Calithera Biosciences, Inc position peaked at $41.3M in Q3 2017.
  • 100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2018.

Based on Viking Global Investors's 13F filing for Q1 2018, filed 15 May 2018.